Quarter Comparison

BIOLARGO, INC.— Sankey Diagram

Quarterly mode · period ending 2025-12-31 · SEC EDGAR

ComparingFY2025 (Q1+Q2+Q3+Q4) vs FY2024 (Q1+Q2+Q3+Q4)
Revenue
$8M
↓-56.3% -$10Mvs FY2024 (Q1+Q2+Q3+Q4)
Gross Profit
$3M
↓-56.6% -$4Mvs FY2024 (Q1+Q2+Q3+Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
Reconciled values per the quarterly mode pipeline. Compare against SEC EDGAR filings.
Line itemFY2025 (Q1+Q2+Q3+Q4)FY2024 (Q1+Q2+Q3+Q4)
Revenue$8M$18M
COGS$4M$10M
Gross Profit$3M$8M
R&D$3M$3M
SG&A$12M$9M
D&A$145K$153K
Other OpEx$0$0
Operating Income$0$0
Interest Exp.$0$0
Other Non-Op$0$0
Pretax Income$0$0
Tax$0$0
Net Income$0$0

QuarterCharts · SEC EDGAR data · BLGO · Comparing FY2025 (Q1+Q2+Q3+Q4) vs FY2024 (Q1+Q2+Q3+Q4)